Comparison of Different Promoter Methylation Assays in Breast Cancer
Background: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influe...
Saved in:
Main Authors: | Karijn P. M. Suijkerbuijk, Xiaojuan Pan, Elsken van der Wall, Paul J. van Diest, Marc Vooijs |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Analytical Cellular Pathology |
Online Access: | http://dx.doi.org/10.3233/ACP-CLO-2010-0542 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conditional Inactivation of HIF-1 Using Intrabodies
by: Arjan J. Groot, et al.
Published: (2008-01-01) -
Expression Pattern of a Homeotic Gene, HOXA5, in Normal Breast and in Breast Tumors
by: Gregory S. Henderson, et al.
Published: (2006-01-01) -
HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
by: Cathy B. Moelans, et al.
Published: (2009-01-01) -
Promoter Methylation Precedes Chromosomal Alterations in Colorectal Cancer Development
by: Sarah Derks, et al.
Published: (2006-01-01) -
A Systematic Comparison Identifies an ATP-Based Viability Assay as Most Suitable Read-Out for Drug Screening in Glioma Stem-Like Cells
by: A. Kleijn, et al.
Published: (2016-01-01)